ENT and Bronchoscopy Devices Market to Surpass USD 30 billion by 2025: Key Players Starkey Hearing Technologies, Smith & Nephew PLC, Olympus Corporation, Karl Storz Gmbh & Co. Kg, Hoya Corporation (Pentax Medical), Sivantos Pte. Ltd., Medtronic PLC

Industry Trend Analysis
The global ENT and bronchoscopy devices market is expected to be around 30 billion by 2025. This can be primarily attributed to number of factors such growing incidences of ENT disorders, rapidly increasing geriatric population, and growing awareness related to availability of treatment devices. Disorders related to the ear such as hearing loss constitute a considerable share of ENT disorders. According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 among every 1,000 children in the U.S. are born with detectable level of hearing impairment in one or both ears. Hearing aids and hearing implants are used to treat the hearing impaired patients. While hearing aids amplify the incoming sound, implants transform sound into electrical signals that stimulate the patient’s auditory nerve.

Product Type Outlook and Trend Analysis
On the basis of product type, the hearing care devices market accounted for the largest share of the global ENT and bronchoscopy in 2016 and is expected to lead the market throughout the forecast period. This is primarily attributed to the growing prevalence of hearing disorders and development of innovative hearing devices.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54991

End User Outlook and Trend Analysis
Hospitals and clinics segment dominated the global market for ENT and bronchoscopy devices in 2016 due to large number of ENT related surgeries performed in the hospitals. This segment accounted for almost half of the overall market in 2016 and will continue to lead the market during the forecast period.

Regional Outlook and Trend Analysis
North America accounted for a majority share of the global ENT and bronchoscopy devices market in 2016 owing to presence of advanced healthcare infrastructure along with favorable reimbursement policies for ENT surgeries in the region. The Asia-Pacific ENT and bronchoscopy devices market is projected to exhibit significant growth during the forecast period due to increasing healthcare expenditure in countries such as China and India along with increased awareness related to the advantages of ENT devices.

Competitive Insights
Development of technologically advanced ENT devices is the key strategy adopted by these players. For instance, in September 2016, Med-El obtained FDA approval for its SYNCHRONY EAS (Electrical Acoustic Stimulation) hearing implant system. This system is a combination of two technologies viz. the Synchrony cochlear implant technology, which is used to stimulate the auditory nerve in high frequency hearing loss, and the SONNET EAS audio processor, which has built-in acoustic amplification used for low frequency hearing loss.

Some of the key players in this market are, Starkey Hearing Technologies, Smith & Nephew PLC, Olympus Corporation, Karl Storz Gmbh & Co. Kg, Hoya Corporation (Pentax Medical), Sivantos Pte. Ltd., Medtronic PLC, Oticon Medical, Endoservice, Maxer Endoscopy, Sopro-Comeg (Acteon Group), William Demant Holding A/S, Entellus Medical, Inc., Johnson & Johnson (Acclarent, Inc.), Sonova Holding AG, MED-EL, OPTOMIC ESPANA S.A., IntriCon Corporation, GN Store Nord A/S, and Cochlear Limited.

Market Opportunities
Technological advancements in ENT diagnostic and surgical devices will offer lucrative growth opportunities for the manufacturers. Latest developments in minimally invasive Trans-Oral Robotic Surgeries (TORS) are highly effective as recovery time for patients undergoing such surgeries is considerably reduced. In these surgeries, surgeons use computer enhanced, sophisticated systems to remove oral cancers assisted by an enhanced view of the existing cancer and the surrounding tissue.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54991

ENT and Bronchoscopy Devices Market Segmentation:
By Product:
Endoscopes
Flexible Endoscopes
Nasopharyngoscopes
Pharyngoscopes
Rhinoscopes
Laryngoscopes
Rigid Endoscopes
Sinuscopes
Otoscopes
Bronchoscopes

Hearing Screening Devices
Surgical ENT & Bronchoscopy Devices
Radiofrequency Devices
Powered Surgical Instruments
Handheld Instruments
Otology Instruments
Rhinology Instruments
Head & Neck Surgical Instruments
Laryngeal Instruments
Other Handheld Instruments

Image-Guided Surgery Systems
Balloon Sinus Dilation Devices
ENT Lasers
Nasal Stents
Bronchial/Tracheal Stents
Ear Tubes
Hearing Care Devices

Hearing Implants
Middle Ear Implants
Bone-Anchored Hearing Systems (BAHS)
Cochlear Implants
Auditory Brainstem Implants

Hearing Aids
Canal Hearing Aids
Behind-the-Ear (BTE) Aids
Receiver-in-the-Ear (RITE)
In-the-Ear Aids

Buy This Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-54991/

By End User:
Ambulatory Surgical Centers (ASCs)
Home Use
Hospitals & Clinics

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
https://www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.